Matthew Cherry, DO
Diagnostic Radiology · Springfield, MONPI 1457376865
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $163,635 of the $163,935 with a category attached, or 99.8%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 91.8% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $28,160, 2.1 times the $13,275 reported in 2019. Among diagnostic radiology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 94 payments — averaging $1743.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$150K
- Shire North American Group Inc$13K
- Greenwich Biosciences, Inc.$211
- Kyowa Kirin, Inc.$49
- CSL Behring$21
What the payments were for
- Consulting fees$163,635100%
- Travel & lodging$190%
- Food & beverage$2810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 68 | $150,440 |
| Shire North American Group Inc | 9 | $13,214 |
| Greenwich Biosciences, Inc. | 13 | $211 |
| Kyowa Kirin, Inc. | 3 | $49 |
| CSL Behring | 1 | $21 |
How this compares
$163,935 in reported general payments places this provider in the 95th percentile of 762 diagnostic radiology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 12 | $110 |
Paid to pharmacies, not to this prescriber.
Other diagnostic radiology in Springfield
- Kimberly PraterSpringfield$1.7M
- Ryan BirlewSpringfield$5K
- Julie AlfordSpringfield$3K
- Kyongtae BaeSaint Louis$232K
- Talissa AltesColumbia$202K
- Jack JenningsSaint Louis$189K
- Ambrose HuangSaint Louis$169K
- Christopher WalkerKansas City$150K
- Laurie FajardoSaint Louis$87K
- Tammie BenzingerSaint Louis$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.